Author Correction: Treatment of liver cirrhosis using hepatocyte-derived liver progenitor-like cells: a prospective, open-label, single-arm, safety trial

Kang He; Xuejing Zhu; Yao Shi; Weijian Huang; Taihua Yang; Zhifeng Xi; Qigen Li; Hanyong Sun; Lijun Qian; Xiaosong Chen; Peiying Li; Xu Zhou; Guiying Gu; Fan Li; Wenming Liu; Cai–Yang Chen; Jie Zhao; Hongping Wu; Fangrong Yan; Michael Ott; Amar Deep Sharma; Hui Liu; Weifeng Yu; Bo Zhai; He‐Xin Yan; Qiang Xia

doi:10.1038/s41421-025-00862-5

Affiliated Institutions

Related Publications

The streaming liver II. Hepatocyte life history

Nadir Arber , G. Zalicek , I. Ariel

ABSTRACT— Thirty male adult rats, were injected with [ 3 H]‐thymidine, [ 3 H]TdR. The animals were killed in groups of five, at the following times: 1 h, 14, 30, 60, 90 and 120 ...

1988 Liver International 120 citations

Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

Jack Gauldie , Carl D. Richards , D.C. Harnish +2 more

One of the oldest and most preserved of the homeostatic responses of the body to injury is the acute phase protein response associated with inflammation. The liver responds to h...

1987 Proceedings of the National Academy o... 1645 citations

Resolving the fibrotic niche of human liver cirrhosis at single-cell level

Prakash Ramachandran , Ross Dobie , John R. Wilson‐Kanamori +25 more

Liver cirrhosis is a major cause of death worldwide and is characterized by extensive fibrosis. There are currently no effective antifibrotic therapies available. To obtain a be...

2019 Nature 1543 citations

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis† ‡

Kittichai Promrat , Glen Lutchman , Gabriel I. Uwaifo +11 more

Nonalcoholic steatohepatitis (NASH) is a common chronic liver disease for which there is no known effective therapy. A proportion of patients with NASH progress to advanced fibr...

2004 Hepatology 723 citations

Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer

Charles S. Fuchs , Toshihiko Doi , Raymond Woo-Jun Jang +26 more

IMPORTANCE Therapeutic options are needed for patients with advanced gastric cancer whose disease has progressed after 2 or more lines of therapy. OBJECTIVE To evaluate the safe...

2018 JAMA Oncology 1757 citations

Publication Info

Year: 2025
Type: erratum
Volume: 11
Issue: 1
Pages: 99-99
Citations: 0
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Author Correction: Treatment of liver cirrhosis using hepatocyte-derived liver progenitor-like cells: a prospective, open-label, single-arm, safety trial

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                
                                    Kang He, 
                                
                                    Xuejing Zhu, 
                                
                                    Yao Shi
                                
                                et al.
                            
                            (2025). 
                            Author Correction: Treatment of liver cirrhosis using hepatocyte-derived liver progenitor-like cells: a prospective, open-label, single-arm, safety trial. 
                            Cell Discovery
                            , 11
                            (1)
                            , 99-99.
                            https://doi.org/10.1038/s41421-025-00862-5
                        

Identifiers

DOI: 10.1038/s41421-025-00862-5